204 related articles for article (PubMed ID: 16235045)
1. The vanadyl (VO2+) chelate bis(acetylacetonato)oxovanadium(IV) potentiates tyrosine phosphorylation of the insulin receptor.
Ou H; Yan L; Mustafi D; Makinen MW; Brady MJ
J Biol Inorg Chem; 2005 Dec; 10(8):874-86. PubMed ID: 16235045
[TBL] [Abstract][Full Text] [Related]
2. Structural origins of the insulin-mimetic activity of bis(acetylacetonato)oxovanadium(IV).
Makinen MW; Brady MJ
J Biol Chem; 2002 Apr; 277(14):12215-20. PubMed ID: 11815612
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of insulin signaling pathway in adipocytes by oxovanadium(IV) complexes.
Basuki W; Hiromura M; Adachi Y; Tayama K; Hattori M; Sakurai H
Biochem Biophys Res Commun; 2006 Oct; 349(3):1163-70. PubMed ID: 16970914
[TBL] [Abstract][Full Text] [Related]
4. Kinetic characterization of the inhibition of protein tyrosine phosphatase-1B by Vanadyl (VO
Hon J; Hwang MS; Charnetzki MA; Rashed IJ; Brady PB; Quillin S; Makinen MW
J Biol Inorg Chem; 2017 Dec; 22(8):1267-1279. PubMed ID: 29071441
[TBL] [Abstract][Full Text] [Related]
5. Amelioration of insulin resistance in diabetic ob/ob mice by a new type of orally active insulin-mimetic vanadyl complex: bis(1-oxy-2-pyridinethiolato)oxovanadium(IV) with VO(S(2)O(2)) coordination mode.
Takeshita S; Kawamura I; Yasuno T; Kimura C; Yamamoto T; Seki J; Tamura A; Sakurai H; Goto T
J Inorg Biochem; 2001 Jun; 85(2-3):179-86. PubMed ID: 11410238
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of bis(maltolato)oxovanadium(IV)-induced insulin signaling in 3T3-L1 and IM9 cells: impact of dexamethasone.
Bose S; Farah MA; Jung HC; Lee JH; Kim Y
J Mol Endocrinol; 2007 Jun; 38(6):627-49. PubMed ID: 17556533
[TBL] [Abstract][Full Text] [Related]
7. The Structural Basis of Action of Vanadyl (VO
Makinen MW; Salehitazangi M
Coord Chem Rev; 2014 Nov; 279():1-22. PubMed ID: 25237207
[TBL] [Abstract][Full Text] [Related]
8. Action mechanism of bis(allixinato)oxovanadium(IV) as a novel potent insulin-mimetic complex: regulation of GLUT4 translocation and FoxO1 transcription factor.
Hiromura M; Nakayama A; Adachi Y; Doi M; Sakurai H
J Biol Inorg Chem; 2007 Nov; 12(8):1275-87. PubMed ID: 17805585
[TBL] [Abstract][Full Text] [Related]
9. Bis(acetylacetonato)-oxovanadium(iv), bis(maltolato)-oxovanadium(iv) and sodium metavanadate induce antilipolytic effects by regulating hormone-sensitive lipase and perilipin via activation of Akt.
Liu JC; Yu Y; Wang G; Wang K; Yang XG
Metallomics; 2013 Jun; 5(7):813-20. PubMed ID: 23576171
[TBL] [Abstract][Full Text] [Related]
10. Bis(alpha-furancarboxylato)oxovanadium(IV) prevents and improves dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
Zuo YQ; Liu WP; Niu YF; Tian CF; Xie MJ; Chen XZ; Li L
J Pharm Pharmacol; 2008 Oct; 60(10):1335-40. PubMed ID: 18812026
[TBL] [Abstract][Full Text] [Related]
11. Involvement of insulin-like growth factor type 1 receptor and protein kinase Cdelta in bis(maltolato)oxovanadium(IV)-induced phosphorylation of protein kinase B in HepG2 cells.
Mehdi MZ; Vardatsikos G; Pandey SK; Srivastava AK
Biochemistry; 2006 Sep; 45(38):11605-15. PubMed ID: 16981720
[TBL] [Abstract][Full Text] [Related]
12. An orally active antidiabetic vanadyl complex, bis(1-oxy-2-pyridinethiolato)oxovanadium(IV), with VO(S2O2) coordination mode; in vitro and in vivo evaluations in rats.
Sakurai H; Sano H; Takino T; Yasui H
J Inorg Biochem; 2000 May; 80(1-2):99-105. PubMed ID: 10885469
[TBL] [Abstract][Full Text] [Related]
13. Structure and conformation of bis(acetylacetonato)oxovanadium(IV) and bis(maltolato)oxovanadium(IV) in solution determined by electron nuclear double resonance spectroscopy.
Mustafi D; Makinen MW
Inorg Chem; 2005 Aug; 44(16):5580-90. PubMed ID: 16060607
[TBL] [Abstract][Full Text] [Related]
14. The effects of intracellular calcium depletion on insulin signaling in 3T3-L1 adipocytes.
Worrall DS; Olefsky JM
Mol Endocrinol; 2002 Feb; 16(2):378-89. PubMed ID: 11818508
[TBL] [Abstract][Full Text] [Related]
15. Chemistry and insulin-mimetic properties of bis(acetylacetonate)oxovanadium(IV) and derivatives.
Amin SS; Cryer K; Zhang B; Dutta SK; Eaton SS; Anderson OP; Miller SM; Reul BA; Brichard SM; Crans DC
Inorg Chem; 2000 Feb; 39(3):406-16. PubMed ID: 11229556
[TBL] [Abstract][Full Text] [Related]
16. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes.
Jarvill-Taylor KJ; Anderson RA; Graves DJ
J Am Coll Nutr; 2001 Aug; 20(4):327-36. PubMed ID: 11506060
[TBL] [Abstract][Full Text] [Related]
17. Protein targeting to glycogen overexpression results in the specific enhancement of glycogen storage in 3T3-L1 adipocytes.
Greenberg CC; Meredith KN; Yan L; Brady MJ
J Biol Chem; 2003 Aug; 278(33):30835-42. PubMed ID: 12805359
[TBL] [Abstract][Full Text] [Related]
18. Bis(6-ethylpicolinato)oxovanadium(IV) complex with normoglycemic activity in KK-A(y) mice.
Sasagawa T; Yoshikawa Y; Kawabe K; Sakurai H; Kojima Y
J Inorg Biochem; 2002 Jan; 88(1):108-12. PubMed ID: 11750032
[TBL] [Abstract][Full Text] [Related]
19. Organo-vanadium compounds are potent activators of the protein kinase B signaling pathway and protein tyrosine phosphorylation: mechanism of insulinomimesis.
Mehdi MZ; Srivastava AK
Arch Biochem Biophys; 2005 Aug; 440(2):158-64. PubMed ID: 16055077
[TBL] [Abstract][Full Text] [Related]
20. New insights into the interactions of serum proteins with bis(maltolato)oxovanadium(IV): transport and biotransformation of insulin-enhancing vanadium pharmaceuticals.
Liboiron BD; Thompson KH; Hanson GR; Lam E; Aebischer N; Orvig C
J Am Chem Soc; 2005 Apr; 127(14):5104-15. PubMed ID: 15810845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]